Biotech Values

[jessellivermore]

BASF takes out PRON....

News on the Omega3 front...

BASF one of AMRN's major API suppliers is closing a buyout deal with PRON..Pronova has amazing facilities for the production of medical grade Omega3s and that BASF is planning to shift these facilities to the manufacture of Vascepa is fairly transparent. The removal of PRON from the scene kills two birds..Eliminates a potential adversary from the patent arena, and allows AMRN much needed increase in API production...

This is a tremendous vote of confidence for AMRN's new drug...

":>) JL